Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - The lancet Respiratory …, 2013 - thelancet.com
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - The Lancet Respiratory …, 2013 - infona.pl
We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker, DE Niewoehner… - 2013 - pubmed.ncbi.nlm.nih.gov
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - The Lancet …, 2013 - europepmc.org
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - The Lancet Respiratory …, 2013 - Elsevier
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
[引用][C] Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK) …
JA Wedzicha, M Decramer, JH Ficker… - LANCET …, 2013 - pure.pmu.ac.at
Analysis of chronic obstructive pulmonary disease exacerbations with the dual
bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): A …
JA Wedzicha, M Decramer, JH Ficker… - The Lancet …, 2013 - experts.umn.edu
Background: We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - Lancet Respiratory …, 2013 - diva-portal.org
Background: We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
[引用][C] Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK) …
JA Wedzicha - Lancet, 2014 - cir.nii.ac.jp
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator
QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double‐blind …
QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double‐blind …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker, DE Niewoehner… - Lancet, 2013 - thelancet.com
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …